BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2001
View Archived Issues
First phase III trial starts for NBI-34060 in chronic (primary) insomnia
Read More
Cellegy submits NDA supplement for Anogesic
Read More
Tetracycline antibiotic finds new use as neuroprotective agent 30 years later
Read More
Replicons kill human glioma cells in preclinical study
Read More
Immune Network and InNexus continue collaboration on antibodies for HIV
Read More
MediGene seeks marketing authorization for Leuprogel in Germany
Read More
New immune system role for enzyme with potential in inflammatory diseases discovered at Lexicon
Read More
Esperion initiates phase II trial of AIM for acute coronary syndromes
Read More
Study shows Combidex can detect malignant lymph nodes in prostate cancer patients
Read More
TransTech and Novo Nordisk enter three-year diabetes research collaboration
Read More
Abbott acquires control of Vysis
Read More
Positive results from phase II trials of HspE7 in HPV-induced sexually transmitted diseases
Read More
Tracleer may now be prescribed for PAH patients in U.S.
Read More
Cannabinoid receptor agonists especially useful for treating pain and neurodegenerative diseases
Read More
Daiichi prepares quinolone antibacterial agents effective in models of pneumonia and sepsis
Read More
Phosphoramidate prodrugs enabling enhanced intracellular delivery of drugs
Read More
Agents for hepatitis C under study at Vertex
Read More
Discovery of novel analgesics reported by AstraZeneca
Read More
Evidence pointing to an immunomodulatory mechanism for antiatherosclerotic effects of DiNAC
Read More
Na+/H+ exchange inhibitor protects against both normo- and hypothermic cardiac ischemia
Read More
SU-11654 inhibits receptor tyrosine kinases, including mutant forms of Kit
Read More
Antithrombotic efficacy reported for LB-30870 following parenteral and oral administration
Read More
Orally active vanillin prodrug as a potential new sickle cell disease therapy
Read More
Thioredoxin-targeting class of antitumor agents synthesized at U.K. university
Read More
Tumor-specific immune responses obtained in aggressive NHL patients given idiotype vaccine
Read More
Nymox reports discovery of clinical candidate for BPH stemming from AD research
Read More